ESR1 and cancer: Of the 409 breast malignancies diagnosed during the study interval in the cancer cohort, 26 (6.4%) cases were TNBC which refers to the fact that the cancer tests negative for estrogen receptors, progesterone receptors, and excess HER2 protein.